Biotech Values

[DewDiligence]

SEC filings:

[More Form-5 filings just came through, so I have updated the info in #1164 and reposted all of it here for convenience.]

Forty-five days from the end of a calendar year (Feb. 14), insiders and major holders of publicly traded companies file their holdings as of Dec 31 with the SEC.

The following info comes from the various forms filed in the past two days. (Note that Osagie Imasogie is not in this list because his options were granted as of 1/1/04.)

ROY LEVITT, CEO
109K shares
1.035M options at exercise prices of $0.40-$11.63

KENNETH HOLROYD, COO
39K shares
661K options at $0.40-$8.00

JOHN ARMSTRONG, EVP
No shares (recent hire)
100K options at $4.45

JOHN SKOLAS, CFO
No shares (recent hire)
100K options at $5.19

ANGELINE SHASHLO, SVP (Regulatory)
No shares
175K options at $0.40-$2.74

SHAPIRO ROBERT, Director
188K shares
90K options at $0.40-$11.63

ZOLA HOROVITZ, Director
29K shares
121K options at $0.40-$10.13

JAMES WYNGAARDEN, Director
5k shares
90K options at $0.40-$10.19

FRANK ECOCK, Director
40K shares
60K options at $0.40-$3.63